Received: 11 August 2021
Accepted: 12 August 2022
First Online: 20 August 2022
: This study was approved by the Kitano Hospital Clinical Research Ethics Committee (Approval Number: 1911003), and all participants provided written informed consent. The study adhered to the tenets of the Declaration of Helsinki.
: All participants provided consent for this publication.
: Masahiko Hara is a stockholder of mediVR, Inc., a company with unlisted stock and ongoing international Patent Cooperation Treaty applications for several patents related to mediVR KAGURA-guided rehabilitation. All other authors have no competing interest to declare.